Poster presentation - Scientific Poster Rating 0

SE-059 - Prospective comparison of spleen size and stiffness measured by magnetic resonance elastography versus shear-wave elastography for non-invasive assessment of clinically significant portal hypertension

Speakers
  • E. Cheong
Authors
  • E. Cheong
  • A. Low
  • C. Ooi
  • M. Tay
  • L. Cheng
  • Y. Hao
  • D. Lau
  • R. Abu Bakar
  • S. Lim
  • A. Gogna
  • C. Too
  • H. Tan
  • C. Tan
  • J. Chang
DOI

10.5444/esgar2020/SE-059

Previous ePoster
SE-058 - Comparison of liver stiffness with laboratory findings in chronic parenchymal liver diseases: Evaluation with 2D Shear Wave US Elastography

Next ePosters
SE-060 - Ultrasonographic Index (USI) for the Diagnosis of Non-Alcoholic Steatohepatitis (NASH) from Non-Alcoholic Fatty Liver Disease (NAFLD)
SE-061 - Liver vein to cava attenuation (LVCA): a simple parameter to increase predictive value of caudate-right lobe ratio (CRL-R) and liver segmental volume ratio (LSVR) to detect significant liver fibrosis on portal venous phase abdominal CT scans
SE-062 - Magnetic Resonance Imaging Features of Primary Biliary Cholangitis
SE-064 - Comparison of Ultrasound Attenuation Imaging and Magnetic Resonance mDIXON-Quant Sequence for the Diagnosis and Severity Grading of Fatty Liver Diseases
SE-065 - Development and preliminary results of a semi-automatic hepatic surface nodularity quantification program
SE-066 - Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients by using Shearwave Elastography in comparison with Transient Elastography
SE-067 - MR imaging findings in autoimmune hepatitis: how frequent and reproducible are they?
SE-068 - Ultrasonographic morphologic diagnosis for chronic liver disease: 2-D shear wave elastography as an add-on test
SE-069 - Impact of respiratory motion and ROI methods on liver stiffness value measurement using shear wave elastography
SE-070 - Liver stiffness: 2D-shear wave elastography can be used with the same cut-off levels than VCTE for the diagnosis of compensated advanced chronic liver disease